Effect of curcuminoids on contrast-induced nephropathy after coronary interventio

Phase 2

Completed

• Conditions: Patient who had Coronary artery disease which undergoing PCI.; Coronary intervention; Curcuminoids; Contrast- induced nephropathy

• Registration Number: TCTR20160721001
• Lead Sponsor: Faculty of Medicine, Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-12-31
• Study Start: 2016-07-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Patient who had Coronary artery disease which undergoing Percutaneous coronary intervention (PCI).

Exclusion Criteria

1. Systolic Blood pressure < 90 mm.Hg.
2. Emergency PCI
3. Acute Renal Failure from other cause
4. Cholestatic jaundice
5. Received Nephrotoxic drug

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
contrast-induced nephropathy After PCI neutrophil gelatinase associated lipocalin (NGAL) level.

Secondary Outcome Measures

Name	Time	Method
Myocardial Necrosis After Percutaneous Coronary Intervention 0, 24 and 48 hour after PCI Cardiac Biomaker